Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BICTEGRAVIR Cause Condition aggravated? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Condition aggravated have been filed in association with BICTEGRAVIR (Biktarvy). This represents 4.3% of all adverse event reports for BICTEGRAVIR.

5
Reports of Condition aggravated with BICTEGRAVIR
4.3%
of all BICTEGRAVIR reports
3
Deaths
3
Hospitalizations

How Dangerous Is Condition aggravated From BICTEGRAVIR?

Of the 5 reports, 3 (60.0%) resulted in death, 3 (60.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.

Is Condition aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BICTEGRAVIR. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does BICTEGRAVIR Cause?

Drug resistance (20) Pathogen resistance (15) Viral mutation identified (12) Treatment noncompliance (9) Immune reconstitution inflammatory syndrome (8) Drug-induced liver injury (6) Death (5) Exposure during pregnancy (5) Virologic failure (5)

What Other Drugs Cause Condition aggravated?

TOFACITINIB (16,925) INFLIXIMAB (16,616) DUPILUMAB (16,459) ETANERCEPT (15,897) METHOTREXATE (14,938) ADALIMUMAB (13,527) PREDNISONE (10,751) INFLIXIMAB-DYYB (10,275) HYDROXYCHLOROQUINE (8,848) RITUXIMAB (8,627)

Which BICTEGRAVIR Alternatives Have Lower Condition aggravated Risk?

BICTEGRAVIR vs BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE BICTEGRAVIR vs BIFIDOBACTERIUM LONGUM BICTEGRAVIR vs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS BICTEGRAVIR vs BILASTINE BICTEGRAVIR vs BIMATOPROST

Related Pages

BICTEGRAVIR Full Profile All Condition aggravated Reports All Drugs Causing Condition aggravated BICTEGRAVIR Demographics